Literature DB >> 7853476

Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles.

T Mebatsion1, M J Schnell, K K Conzelmann.   

Abstract

A reverse genetics approach which allows the generation of infectious defective rabies virus (RV) particles entirely from plasmid-encoded genomes and proteins (K.-K. Conzelmann and M. Schnell, J. Virol. 68:713-719, 1994) was used to investigate the ability of a heterologous lyssavirus glycoprotein (G) and chimeric G constructs to function in the formation of infectious RV-like particles. Virions containing a chloramphenicol acetyltransferase (CAT) reporter gene (SDI-CAT) were generated in cells simultaneously expressing the genomic RNA analog, the RV N, P, M, and L proteins, and engineered G constructs from transfected plasmids. The infectivity of particles was determined by a CAT assay after passage to helper virus-infected cells. The heterologous G protein from Eth-16 virus (Mokola virus, lyssavirus serotype 3) as well as a construct in which the ectodomain of RV G was fused to the cytoplasmic and transmembrane domains of the Eth-16 virus G rescued infectious SDI-CAT particles. In contrast, a chimeric protein composed of the amino-terminal half of the Eth-16 virus G and the carboxy-terminal half of RV G failed to produce infectious particles. Site-directed mutagenesis was used to convert the antigenic site III of RV G to the corresponding sequence of Eth-16 G. This chimeric protein rescued infectious SDI-CAT particles as efficiently as RV G. Virions containing the chimeric protein were specifically neutralized by an anti-Eth-16 virus serum and escaped neutralization by a monoclonal antibody directed against RV antigenic site III. The results show that entire structural domains as well as short surface epitopes of lyssavirus G proteins may be exchanged without affecting the structure required to mediate infection of cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853476      PMCID: PMC188731     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Antigenic properties of rabies virus components.

Authors:  T J Wiktor; E György; D Schlumberger; F Sokol; H Koprowski
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

2.  Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies.

Authors:  M Lafon; J Ideler; W H Wunner
Journal:  Dev Biol Stand       Date:  1984

3.  Molecular analysis of rabies-related viruses from Ethiopia.

Authors:  T Mebatsion; J H Cox; K K Conzelmann
Journal:  Onderstepoort J Vet Res       Date:  1993-12       Impact factor: 1.792

4.  Structure of the glycoprotein gene in rabies virus.

Authors:  A Anilionis; W H Wunner; P J Curtis
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

5.  Molecular basis of rabies virus virulence. II. Identification of a site on the CVS glycoprotein associated with virulence.

Authors:  P Coulon; P E Rollin; A Flamand
Journal:  J Gen Virol       Date:  1983-03       Impact factor: 3.891

6.  Use of protein A-bearing staphylococci for the immunoprecipitation and isolation of antigens from cells.

Authors:  S W Kessler
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

7.  Rabies virus glycoprotein analogs: biosynthesis in Escherichia coli.

Authors:  E Yelverton; S Norton; J F Obijeski; D V Goeddel
Journal:  Science       Date:  1983-02-11       Impact factor: 47.728

8.  Characterization of saturable binding sites for rabies virus.

Authors:  W H Wunner; K J Reagan; H Koprowski
Journal:  J Virol       Date:  1984-06       Impact factor: 5.103

9.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

10.  Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.

Authors:  B Dietzschold; W H Wunner; T J Wiktor; A D Lopes; M Lafon; C L Smith; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  23 in total

1.  Highly stable expression of a foreign gene from rabies virus vectors.

Authors:  T Mebatsion; M J Schnell; J H Cox; S Finke; K K Conzelmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 3.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

4.  Folding of rabies virus glycoprotein: epitope acquisition and interaction with endoplasmic reticulum chaperones.

Authors:  Y Gaudin
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

Review 5.  Genetic engineering of animal RNA viruses.

Authors:  K K Conzelmann; G Meyers
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

6.  Specific infection of CD4+ target cells by recombinant rabies virus pseudotypes carrying the HIV-1 envelope spike protein.

Authors:  T Mebatsion; K K Conzelmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 7.  Rhabdoviruses as vectors for vaccines and therapeutics.

Authors:  Gabrielle Scher; Matthias J Schnell
Journal:  Curr Opin Virol       Date:  2020-10-29       Impact factor: 7.090

8.  A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.

Authors:  H D Foley; J P McGettigan; C A Siler; B Dietzschold; M J Schnell
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

9.  Chimeric lyssavirus glycoproteins with increased immunological potential.

Authors:  C Jallet; Y Jacob; C Bahloul; A Drings; E Desmezieres; N Tordo; P Perrin
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.